Nigral and extranigral pathology in Parkinson's disease

被引:0
|
作者
Braak, H [1 ]
Braak, E [1 ]
Yilmazer, D [1 ]
Schultz, C [1 ]
deVos, RAI [1 ]
Jansen, ENH [1 ]
机构
[1] STREEKLAB PATHOL, ENSCHEDE, NETHERLANDS
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This article reviews data on the internal organization, neuronal types, and interconnections of limbic and motor components of the human brain, and the specific lesions which a few of them undergo during the course of Parkinson's disease (neuronal loss associated with the development of Lewy bodies and Lewy neurites). The severe involvement of nigral neuromelanin-laden projection cells has received particular attention during the past decades. This lesion interferes with normal function of the striatum and probably contributes to many of the motor dysfunctions characteristically occurring in Parkinson's disease. The similarly severe involvement of several areas and nuclei outside of the substantia nigra has often escaped notice. However, the pathology of Parkinson's disease cannot be completely described unless changes in these extranigral areas are taken into account. Interpretation of the characteristic lesional pattern is facilitated by combining schemata of both the limbic and motor systems. This approach reveals a key role by the amygdala and related structures in extranigral pathology. Severe lesions occur in the central amygdaloid nucleus, in nuclei projecting to the cerebral cortex in a non-specific manner, and in nuclei regulating endocrine and autonomic functions. It is suggested that extranigral lesions contribute to the development of behavioral changes and autonomic dysfunction.
引用
收藏
页码:15 / 31
页数:17
相关论文
共 50 条
  • [21] Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease
    Ziegler, Erik
    Rouillard, Maud
    Andre, Elodie
    Coolen, Tim
    Stender, Johan
    Balteau, Evelyne
    Phillips, Christophe
    Garraux, Gaetan
    NEUROIMAGE, 2014, 99 : 498 - 508
  • [22] Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
    Jeffrey H Kordower
    Yaping Chu
    Robert A Hauser
    Thomas B Freeman
    C Warren Olanow
    Nature Medicine, 2008, 14 : 504 - 506
  • [23] Parkinson Disease: Extranigral, Multisystem, and α-Synuclein "Plus" Reply
    Lim, Shen-Yang
    Fox, Susan H.
    Lang, Anthony E.
    ARCHIVES OF NEUROLOGY, 2009, 66 (07) : 915 - 916
  • [24] Fetal nigral transplantation as a therapy for Parkinson's disease
    Olanow, CW
    Kordower, JH
    Freeman, TB
    TRENDS IN NEUROSCIENCES, 1996, 19 (03) : 102 - 109
  • [25] Height and nigral neuron density in Parkinson's disease
    Saari, L.
    Backman, E.
    Wahlsten, P.
    Gardberg, M.
    Kaasinen, V.
    MOVEMENT DISORDERS, 2022, 37 : S527 - S528
  • [26] Nigral endothelial dysfunction, homocysteine, and Parkinson's disease
    Müller, T
    Werne, B
    Fowler, B
    Kuhn, W
    LANCET, 1999, 354 (9173): : 126 - 127
  • [27] Nigral iron susceptibility in Parkinson's disease (PD)
    Bastida, A. Martin
    Politis, M.
    Loane, C.
    Lao-Kaim, N.
    Valle-Guzman, N.
    Kefalopoulou, Z.
    Paul, G.
    Widner, H.
    Foltynie, T.
    Barker, R.
    Piccini, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 67 - 67
  • [28] Pathogenesis of nigral cell death in Parkinson's disease
    Przedborski, S
    PARKINSONISM & RELATED DISORDERS, 2005, 11 : S3 - S7
  • [29] Height and nigral neuron density in Parkinson's disease
    Saari, Laura
    Backman, Emmilotta A.
    Wahlsten, Pia
    Gardberg, Maria
    Kaasinen, Valtteri
    BMC NEUROLOGY, 2022, 22 (01)
  • [30] Height and nigral neuron density in Parkinson’s disease
    Laura Saari
    Emmilotta A. Backman
    Pia Wahlsten
    Maria Gardberg
    Valtteri Kaasinen
    BMC Neurology, 22